Diagnostics
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
9,090,868
NCT06162533
Severe Acute Respiratory Syndrome Coronavirus 2 Re-Infection Risk and Vaccine Efficacy in Austria
Phase: N/A
Role: Collaborator
Start: Jul 1, 2023
Completion: Jul 1, 2023
Loading map...